Description: InMed Pharma (CSE: IN, OTCQB: IMLFF) is a clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. InMed’s proprietary platform technology, product pipeline and accelerated development pathway are the fundamental value drivers of the company.
November 16, 2017
InMed to Present at Cannabis-Based Science & Medicine Conference
November 14, 2017
InMed Reports No Material Change
Want to learn more about InMed Pharmaceuticals?
Note: page will reload once form is submitted.
#340-200 Granville Street
Canada V6C 1S4
Phone: (604) 669-7207
Email: [email protected]